Global Health & Medicine

Drug development targeting SARS-CoV-2 main protease

Bulut H

Global Health & Medicine. 2022; 4(6):296-300.

DOI: 10.35772/ghm.2022.01066

Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer

Karayama M, Mizoguchi Y, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Kitano S, Aoki K, Yamada Y

Global Health & Medicine. 2022; 4(6):301-308.

DOI: 10.35772/ghm.2022.01052

Outcomes following cholecystectomy in human immunodeficiency virus-positive patients treated with antiretroviral therapy: A retrospective cohort study

Aso K, Ito K, Takemura N, Tsukada K, Inagaki F, Mihara F, Oka S, Kokudo N

Global Health & Medicine. 2022; 4(6):309-314.

DOI: 10.35772/ghm.2022.01051

Short- and long-term efficacy of bronchial artery embolization using a gelatin sponge for the treatment of cryptogenic hemoptysis

Nagano N, Suzuki M, Yamamoto S, Kobayashi K, Iikura M, Izumi S, Hojo M, Sugiyama H

Global Health & Medicine. 2022; 4(6):315-321.

DOI: 10.35772/ghm.2022.01057

Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant

Liao XJ, Guan Y, Liao QB, Ma ZH, Zhang LP, Dong JK, Lai XJ, Zheng GQ, Yang SM, Wang C, Liao ZH, Song S, Yi HY, Lu HZ

Global Health & Medicine. 2022; 4(6):322-326.

DOI: 10.35772/ghm.2022.01069

Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in Japan

Kamegai K, Hayakawa K

Global Health & Medicine. 2022; 4(6):327-331.

DOI: 10.35772/ghm.2022.01071

Infection control of COVID-19 in operating theaters in a designated hospital for specified infectious diseases in Japan

Yamada K, Hara T, Sato K, Koyama Y, Kato D, Nohara K, Enomoto N, Yagi S, Kitagawa D, Takemura N, Nagasaka S, Kiyomatsu T, Kokudo N

Global Health & Medicine. 2022; 4(6):332-335.

DOI: 10.35772/ghm.2022.01042

Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19

Uchihara M, Kodani N, Bouchi R, Saito S, Miyazato Y, Sugimoto H, Umamoto K, Kobayashi M, Ihana-Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H

Global Health & Medicine. 2022; 4(6):336-340.

DOI: 10.35772/ghm.2022.01053

Challenges and the potential of promoting remote medical interpreting during COVID-19

Saeki S, Iwata M, Tomizawa R, Minamitani K

Global Health & Medicine. 2022; 4(6):341-346.

DOI: 10.35772/ghm.2022.01056

Gastrointestinal endoscopy trends in a designated hospital for specified infectious diseases in Japan during the dawn of the "living with COVID-19" era

Yokoi C, Yanai Y, Suzuki K, Akazawa N, Yamamoto N, Akiyama J

Global Health & Medicine. 2022; 4(6):347-349.

DOI: 10.35772/ghm.2022.01021